116 related articles for article (PubMed ID: 20883704)
21. p53 enters the microRNA world.
Hermeking H
Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
[TBL] [Abstract][Full Text] [Related]
22. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
[TBL] [Abstract][Full Text] [Related]
23. miR-10 in development and cancer.
Lund AH
Cell Death Differ; 2010 Feb; 17(2):209-14. PubMed ID: 19461655
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
Welch C; Chen Y; Stallings RL
Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
[TBL] [Abstract][Full Text] [Related]
26. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
28. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
29. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
Chen F; Hu SJ
J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
Xu RS; Wu XD; Zhang SQ; Li CF; Yang L; Li DD; Zhang BG; Zhang Y; Jin JP; Zhang B
Int J Oncol; 2013 Feb; 42(2):676-82. PubMed ID: 23258531
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
32. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis.
Wang YX; Zhang XY; Zhang BF; Yang CQ; Chen XM; Gao HJ
J Dig Dis; 2010 Feb; 11(1):50-4. PubMed ID: 20132431
[TBL] [Abstract][Full Text] [Related]
33. [Differential expression of colon cancer microRNA in microarry study].
Ma Q; Yang L; Wang C; Yu YY; Zhou B; Zhou ZG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):344-8. PubMed ID: 21826996
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
Li X; Zhao H; Zhou X; Song L
Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
[TBL] [Abstract][Full Text] [Related]
35. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).
Wong MY; Yu Y; Walsh WR; Yang JL
Int J Oncol; 2011 May; 38(5):1189-95. PubMed ID: 21399872
[TBL] [Abstract][Full Text] [Related]
36. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
[TBL] [Abstract][Full Text] [Related]
37. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH.
Kim HR; Roe JS; Lee JE; Hwang IY; Cho EJ; Youn HD
Biochem Biophys Res Commun; 2012 Feb; 418(4):682-8. PubMed ID: 22301190
[TBL] [Abstract][Full Text] [Related]
38. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.
Li Y; Gong P; Hou JX; Huang W; Ma XP; Wang YL; Li J; Cui XB; Li N
J Immunol Res; 2018; 2018():7498514. PubMed ID: 30175154
[TBL] [Abstract][Full Text] [Related]
39. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-143 and -145 in colon cancer.
Akao Y; Nakagawa Y; Naoe T
DNA Cell Biol; 2007 May; 26(5):311-20. PubMed ID: 17504027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
